Archives

30
Jun

ACS-IRG Pilot Projects Awarded for 2010

The Kimmel Cancer Center at Jefferson hosted the 3rd Annual ACS-IRG Luncheon on June 16, 2010. The 2010 Pilot Project recipients are Nancy Hodgson, RN, PhD of the Jefferson Center for Applied Research in Aging and Health, Amy Leader, DrPh, MPh and Hushan Yang, PhD, both of the department of Medical Oncology.

24
May

Scientists Find Protein Spurs Spread of Prostate Cancer

Researchers from the Kimmel Cancer Center at Jefferson have found that Stat5, a signaling protein previously found to be key to survival of prostate cancer, is also involved in metastasis. Their study, published in the online edition of Endocrine-Related Cancer, demonstrates in both laboratory and animal models that nuclear Stat5 over-expression leads to a deadly …

5
May

KCC American Cancer Society Research Symposium

The Kimmel Cancer Center at Jefferson hosted the 2nd Annual American Cancer Society Research Symposium: Celebrating the ACS Institutional Research Grant at KCC on April 16, 2010. Dr. Pestell welcomed members of the KCC and TJU community and the American Cancer Society. Michael Lisanti, MD, PhD was the Keynote Speaker presenting “The Reverse Warburg Effect: …

26
Jun

ACS-IRG Luncheon

The Kimmel Cancer Center at Jefferson hosted the 2nd Annual ACS-IRG Luncheon on June 25, 2009. Representatives of the Southeast Region, Pennsylvania Division of the American Cancer Society had an opportunity to meet this year’s recipients of the Pilot Project Awards from the Kimmel Cancer Center’s American Cancer Society Institutional Research Grant, Richard G. Pestell …

18
Jun

Blocking Signaling Protein Prevents Prostate Cancer Spread, Jefferson Scientists Find

Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have shown that by blocking a signaling protein, they can prevent prostate cancer cells from metastatic dissemination. The work opens the door to future studies examining the protein as a target for therapies aimed at keeping prostate cancer at bay. In a series of experiments …

29
Feb

Blocking Growth Protein Kills Prostate Cancer Cells, Inhibits Tumor Growth, Jefferson Scientists Find

Researchers at Jefferson’s Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer’s growth. The work proves that the protein, Stat5, is both vital to prostate cancer cell maintenance and …

3
Jan

Jefferson Scientists Find Cell Growth Protein Potential Drug Target for Treatment-Resistant Prostate Cancer

Scientists at Jefferson’s Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. If the findings hold up, the protein, called Stat5, may be a specific drug target against an extremely …